Value of lung diffusing capacity for nitric oxide in systemic sclerosis

Value of lung diffusing capacity for nitric oxide in systemic sclerosis

Abstract A decreased lung diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis (SSc) is considered to reflect losses of alveolar membrane diffusive conductance for CO (DMCO), due to interstitial lung disease, and/or pulmonary capillary blood volume (VC), due to vasculopathy. However,...

Full description

Bibliographic Details
Main Authors:	Giovanni Barisione, Alessandro Garlaschi, Mariaelena Occhipinti, Michele Baroffio, Massimo Pistolesi, Vito Brusasco
Format:	Article
Language:	English
Published:	Wiley 2019-07-01
Series:	Physiological Reports
Subjects:	Interstitial lung disease lung diffusing capacity for carbon monoxide lung diffusing capacity for nitric oxide systemic sclerosis
Online Access:	https://doi.org/10.14814/phy2.14149

Similar Items

Lung diffusing capacity for nitric oxide and carbon monoxide following mild‐to‐severe COVID‐19
by: Giovanni Barisione, et al.
Published: (2021-02-01)

INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2017-03-01)

Pulmonary Outcomes in Children Born Extremely and Very Preterm at 11 Years of Age
by: Paola Di Filippo, et al.
Published: (2021-05-01)

LUNG DIFFUSION CAPACITY CAN PREDICT MAXIMAL EXERCISE IN APPARENTLY HEALTHY HEAVY SMOKERS
by: Alfredo Chetta, et al.
Published: (2008-06-01)

Detection of pulmonary involvement in lupus patients with and without clinical pulmonary symptoms
by: Hala A. Mohammad, et al.
Published: (2014-04-01)

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
by: Anna Winkler, et al.
Published: (2018-09-01)

Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study
by: Yu-Yue Zhao, et al.
Published: (2015-01-01)

Interplay between the morphometry of the lungs and the mode of locomotion in birds and mammals
by: DANIELA FIGUEROA, et al.
Published: (2007-01-01)

Pulmonary involvement in systemic sclerosis: A clinical profile
by: A S Deepa, et al.
Published: (2016-01-01)

Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective
by: Diana E. Amariei, et al.
Published: (2019-09-01)

Single-breath diffusion capacity of the lung for carbon monoxide in chronic obstructive pulmonary disease
by: Waleed M. El-Sorougi, et al.
Published: (2017-01-01)

The effect of selective internal radiation therapy with yttrium-90 resin microspheres on lung carbon monoxide diffusion capacity
by: Tunc Ones, et al.
Published: (2017-12-01)

Lung Transfer Factor in Middle Aged Asymptomatic Male Smokers of a City from West India: A Cross-Sectional Study
by: Bhakti P. Gadhavi, et al.
Published: (2016-03-01)

Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age
by: Xiaolei Tang, et al.
Published: (2020-01-01)

Lung clearance index and diffusion capacity for CO to detect early functional pulmonary impairment in children with rheumatic diseases
by: Julia Hildebrandt, et al.
Published: (2021-03-01)

Unexpected radiation pneumonitis after SIRT with significant decrease in DLCO with internal radiation exposure: a case report
by: Selin Kesim, et al.
Published: (2020-05-01)

TNMC-GAP (The New Modified Classification of Gender Age Physiology)- A novel risk assessment system in idiopathic pulmonary fibrosis
by: Unnati D Desai, et al.
Published: (2018-01-01)

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
by: Sara Jaafar, et al.
Published: (2021-06-01)

Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial
by: Thomas Radtke, et al.
Published: (2018-06-01)

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
by: Berchtold, J., et al.
Published: (2022)

LUNG DIFFUSION CAPACITY AND NON-SPECIFIC INFLAMMATION MARKERS IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS
by: E. D. Bazdyrev, et al.
Published: (2013-12-01)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
by: Bergamasco A, et al.
Published: (2019-04-01)

UP-FRONT TRIPLE COMBINATION THERAPY FOR PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A CASE REPORT
by: A. V. Volkov, et al.
Published: (2018-03-01)

Evaluation of the questionnaires’ validity in assessing the severity of idiopathic pulmonary fibrosis in correlation with high-resolution computed tomography, lung diffusion, and cardiopulmonary exercise tests
by: Taher El Naggar, et al.
Published: (2017-04-01)

Lung function in relation to exercise capacity in health and disease
by: Farkhooy, Amir
Published: (2017)

Relations between vital capacity, CO diffusion capacity and computed tomographic findings of former asbestos-exposed patients: a cross-sectional study
by: Alexandra Marita Preisser, et al.
Published: (2020-07-01)

Prediction equations for diffusing capacity (transfer factor) of lung for North Indians
by: Sunil Kumar Chhabra, et al.
Published: (2016-01-01)

Reference values for lung function tests: III. Carbon monoxide diffusing capacity (transfer factor)
by: Neder J.A., et al.
Published: (1999-01-01)

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
by: A.U. Wells
Published: (2010-09-01)

How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients
by: Pierantonio Laveneziana, et al.
Published: (2021-06-01)

Treatment of Systemic Sclerosis Associated Interstitial Lung Disease
by: Iris Yan Ki Tang, et al.
Published: (2020-12-01)

Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies
by: Sakir Ahmed, et al.
Published: (2018-01-01)

Matrix metalloproteinase 7 is a candidate biomarker in systemic sclerosis-associated interstitial lung disease
by: Zhixiao Xu, et al.
Published: (2020-07-01)

Demographic characteristics and clinical manifestations of interstitial lung disease with systemic sclerosis in eastern part of Libya
by: Fathi M Elbraky, et al.
Published: (2021-01-01)

Usefulness of surgical lung biopsies after cryobiopsies when pathological results are inconclusive or show a pattern suggestive of a nonspecific interstitial pneumonia
by: Benjamin Bondue, et al.
Published: (2020-09-01)

Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons
by: Krzysztof Kuziemski, et al.
Published: (2019-01-01)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
by: Zarir F Udwadia, et al.
Published: (2015-01-01)

Transbronchial cryobiopsy in diffuse parenchymal lung disease
by: Kamonpun Ussavarungsi, et al.
Published: (2015-07-01)

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
by: Sabine Adler, et al.
Published: (2018-01-01)

Assessment of functional lung impairment in patients with thyroid disorders
by: Eman R. Ali
Published: (2016-11-01)